AAAAAA

   
Results: 1-9 |
Results: 9
Cross-linking of LFA-1 molecule enhances Fas mediated apoptosis of Jurkat and Burkitt lymphoma cell lines
Authors: Krzyzowska, M Sabri, F De Milito, A Missailidis, C Schollenberger, A Niemialtowski, MG Chiodi, F
Citation: M. Krzyzowska et al., Cross-linking of LFA-1 molecule enhances Fas mediated apoptosis of Jurkat and Burkitt lymphoma cell lines, CELL DEAT D, 8(11), 2001, pp. 1123-1124
Loss of memory (CD27) B lymphocytes in HIV-1 infection
Authors: De Milito, A Morch, C Sonnerborg, AS Chiodi, F
Citation: A. De Milito et al., Loss of memory (CD27) B lymphocytes in HIV-1 infection, AIDS, 15(8), 2001, pp. 957-964
Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex
Authors: Sabri, F De Milito, A Pirskanen, R Elovaara, I Hagberg, L Cinque, P Price, R Chiodi, F
Citation: F. Sabri et al., Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex, J NEUROIMM, 114(1-2), 2001, pp. 197-206
High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy
Authors: De Milito, A Hejdeman, B Albert, J Aleman, S Sonnerborg, A Zazzi, M Chiodi, F
Citation: A. De Milito et al., High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy, AIDS RES H, 16(14), 2000, pp. 1379-1384
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors
Authors: Catucci, M Venturi, G Romano, L Riccio, ML De Milito, A Valensin, PE Zazzi, M
Citation: M. Catucci et al., Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors, J ACQ IMM D, 21(3), 1999, pp. 203-208
Genotypic resistance to zidovudine as a predictor of failure of subsequenttherapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors
Authors: Venturi, G Romano, L Catucci, M Riccio, ML De Milito, A Gonnelli, A Rubino, M Valensin, PE Zazzi, M
Citation: G. Venturi et al., Genotypic resistance to zidovudine as a predictor of failure of subsequenttherapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors, EUR J CL M, 18(4), 1999, pp. 274-282
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients
Authors: De Milito, A Catucci, M Venturi, G Romano, L Incandela, L Valensin, PE Zazzi, M
Citation: A. De Milito et al., Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients, J MED VIROL, 57(2), 1999, pp. 140-144
Clinical evaluation of an in-house reverse transcription competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma
Authors: Zazzi, M Romano, L Catucci, M Venturi, G De Milito, A Valensin, PE
Citation: M. Zazzi et al., Clinical evaluation of an in-house reverse transcription competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma, J CLIN MICR, 37(2), 1999, pp. 333-338
Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy
Authors: Romano, L Venturi, G Catucci, M De Milito, A Valensin, PE Zazzi, M
Citation: L. Romano et al., Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy, J INFEC DIS, 179(2), 1999, pp. 361-366
Risultati: 1-9 |